← Home
Agree Realty Corp
-15.44%
Real estate / REIT Retail
📢 Press Releases
| Date | Press release |
|---|---|
| 2025-05-15 07:15:00 | Adc Therapeutics To Present At Upcoming Investor Conferences Lausanne, switzerland , may 15, 2025 /prnewswire/ -- adc therapeutics sa (nyse: adct), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (adcs), today announced participation in two upcoming investor conferences: rbc capital markets global healthcare conferencedate: may 21, 2025 presentation time: 10:30-10:55 a.m. et format: fireside chatspeaker: ameet mallik, chief executive officerto register for the webcast, click here. |
| 2025-05-14 16:24:00 | Agree Realty Announces Pricing Of $400 Million Of 5.600% Senior Unsecured Notes Due 2035 Inclusive of prior hedging activity the all-in interest rate of the notes is 5.35% royal oak, mich. , may 14, 2025 /prnewswire/ -- agree realty corporation (nyse: adc) (the ’company’) today announced that its operating partnership, agree limited partnership (the ’operating partnership’), priced a public offering of $400 million of its 5.600% senior unsecured notes due 2035 (the ’notes’). |
| 2025-05-14 08:00:00 | Adc Therapeutics Reports First Quarter 2025 Financial Results And Provides Operational Update Lotis-7 abstract accepted for presentation at the european hematology association 2025 congress (eha2025) and the 18th international conference on malignant lymphoma (icml); zynlonta® plus glofitamab demonstrated orr of 95.5% and cr of 90.9% with encouraging safety and tolerability forty patient enrollment reached in lotis-7 trial dose expansion arm in patients with relapsed/refractory dlbcl cash runway expected to fund multiple catalysts into the second half of 2026 company to host conference call today at 8:30 a.m. edt lausanne, switzerland , may 14, 2025 /prnewswire/ -- adc therapeutics sa (nyse: adct), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (adcs), today reported financial results for the first quarter ended march 31, 2025, and provided recent operational updates. |
| 2025-05-14 07:45:00 | Adc Therapeutics Announces Presentation Of Lotis-7 Clinical Trial Data At The European Hematology Association 2025 Congress (eha2025) And The 18th International Conference On Malignant Lymphoma (icml) Zynlonta ® plus glofitamab (columvi®) demonstrated orr of 95.5% and cr of 90.9%, among 22 evaluable patients with relapsed/refractory dlbcl safety and tolerability data were consistent with the known profiles of each agent updated data to be shared during poster presentation at eha2025 on saturday, june 14 at 12:30 p.m. et and oral presentation at icml on friday, june 20 at 9:00 a.m. |
| 2025-05-13 16:05:00 | Agree Realty Declares Monthly Common And Preferred Dividends Royal oak, mich. , may 13, 2025 /prnewswire/ -- agree realty corporation (nyse: adc) (the ’company’) today announced that its board of directors has authorized, and the company has declared, a monthly cash dividend of $0.256 per common share. |
| 2025-05-08 07:15:00 |
|
| 2025-04-28 16:05:00 |
|
| 2025-04-28 07:00:00 |
|
| 2025-04-25 16:05:00 |
|
| 2025-04-25 13:17:00 |
|
| 2025-04-24 08:00:00 |
|
| 2025-04-23 21:50:00 |
|
| 2025-04-23 16:05:00 |
|
| 2025-04-22 16:05:00 |
|
| 2025-04-10 16:05:00 |
|
📰 Browse additional press releases for Agree Realty Corp!
Sign up for free or log in🙌 Join now to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" at no cost